Totally agree.
1. This is not your typical OTC Management Team. How many OTC companies have management with senior leadership experience in large cap companies like Coca-Cola, Kraft, Molsons, Heinz, etc.
2. This is not your typical OTC Company. How many OTC companies will have revenues pushing $200M this year. Last fall this company was on their way to a Nasdaq listing. We know what happened there, but I still believe that is this companies future. This company had a market cap of around $350M 6 months ago....and revenues that are growing exponentially each Q.
I get that the stock went into a death spiral once the Nasdaq filing was abandoned. I get the dilution we have had based on that toxic debt. But the debt has been addressed and the financials have improved over the past 6 months.
IMO this stock is way undervalued right now.
